Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 16 holding rows worth $33,971,000.

Accession
0000919574-20-001552
Filed
2020-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 16 entries on the cover page, a total value of $33,971,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $33,971,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR100,000$4,699,000thousands by filing date
Gilead Sciences,Inc.375558103COM70,000$4,549,000thousands by filing date
AbbVie,Inc.00287Y109COM50,000$4,427,000thousands by filing date
CVS Health Corporation126650100COM50,000$3,715,000thousands by filing date
TYME TECHNOLOGIES INC COM90238J103Stock2,175,000$3,045,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM250,000$2,005,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM35,000$1,770,000thousands by filing date
CENCORA INC COM03073E105Stock20,000$1,700,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM150,000$1,564,000thousands by filing date
ANTARES PHARMA INC036642106COM300,000$1,410,000thousands by filing date
MCKESSON CORP COM58155Q103Stock10,000$1,383,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS350,000$1,166,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM100,000$1,043,000thousands by filing datecall
ADAMAS PHARMACEUTICALS INC00548A106COM200,000$758,000thousands by filing datecall
GREENLANE HLDGS INC395330103CL A175,000$570,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS50,000$167,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-20-001552this filing2020-02-14acceptance time not in the bulk data set